Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer - Schwartz, G G; Hall, M C; Stindt, D; Patton, S; Lovato, J; Torti, F M (Clin Cancer Res, 2005)